Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3190595938;95939;95940 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
N2AB3026491015;91016;91017 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
N2A2933788234;88235;88236 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
N2B2284068743;68744;68745 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
Novex-12296569118;69119;69120 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
Novex-22303269319;69320;69321 chr2:178545397;178545396;178545395chr2:179410124;179410123;179410122
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-120
  • Domain position: 99
  • Structural Position: 132
  • Q(SASA): 1.167
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/Q rs777381153 0.395 0.993 N 0.628 0.229 0.216624796971 gnomAD-2.1.1 4.5E-06 None None None None N None 0 0 None 0 0 None 4.13E-05 None 0 0 0
E/Q rs777381153 0.395 0.993 N 0.628 0.229 0.216624796971 gnomAD-4.0.0 2.11808E-06 None None None None N None 0 0 None 0 0 None 0 0 0 3.78444E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.211 likely_benign 0.2264 benign -0.199 Destabilizing 0.976 D 0.72 deleterious N 0.445306408 None None N
E/C 0.8658 likely_pathogenic 0.8952 pathogenic -0.199 Destabilizing 1.0 D 0.721 deleterious None None None None N
E/D 0.0983 likely_benign 0.1154 benign -0.333 Destabilizing 0.026 N 0.388 neutral N 0.334677278 None None N
E/F 0.7711 likely_pathogenic 0.8033 pathogenic -0.117 Destabilizing 1.0 D 0.579 neutral None None None None N
E/G 0.2537 likely_benign 0.2863 benign -0.356 Destabilizing 0.953 D 0.477 neutral N 0.467201833 None None N
E/H 0.645 likely_pathogenic 0.6738 pathogenic 0.376 Stabilizing 1.0 D 0.65 prob.neutral None None None None N
E/I 0.4135 ambiguous 0.4345 ambiguous 0.169 Stabilizing 0.998 D 0.617 neutral None None None None N
E/K 0.3446 ambiguous 0.3558 ambiguous 0.363 Stabilizing 0.953 D 0.709 prob.delet. N 0.476994752 None None N
E/L 0.4297 ambiguous 0.4478 ambiguous 0.169 Stabilizing 0.995 D 0.638 neutral None None None None N
E/M 0.5102 ambiguous 0.5243 ambiguous 0.022 Stabilizing 1.0 D 0.611 neutral None None None None N
E/N 0.3022 likely_benign 0.3328 benign 0.042 Stabilizing 0.99 D 0.685 prob.delet. None None None None N
E/P 0.4861 ambiguous 0.5344 ambiguous 0.065 Stabilizing 0.998 D 0.623 neutral None None None None N
E/Q 0.2307 likely_benign 0.2352 benign 0.066 Stabilizing 0.993 D 0.628 neutral N 0.493233641 None None N
E/R 0.5045 ambiguous 0.5407 ambiguous 0.634 Stabilizing 0.995 D 0.689 prob.delet. None None None None N
E/S 0.2669 likely_benign 0.2954 benign -0.099 Destabilizing 0.964 D 0.716 prob.delet. None None None None N
E/T 0.3161 likely_benign 0.3455 ambiguous 0.035 Stabilizing 0.995 D 0.654 prob.neutral None None None None N
E/V 0.246 likely_benign 0.258 benign 0.065 Stabilizing 0.998 D 0.574 neutral N 0.466335041 None None N
E/W 0.927 likely_pathogenic 0.938 pathogenic -0.003 Destabilizing 1.0 D 0.731 deleterious None None None None N
E/Y 0.6264 likely_pathogenic 0.6771 pathogenic 0.122 Stabilizing 1.0 D 0.511 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.